BioNxt Solutions在私人安置方面筹集了1.25亿美元,用于资助药物提供技术开发。 BioNxt Solutions raises $1.25M in private placement to fund drug delivery tech development.

生物科学公司BioNxt Solutions已经完成了私人安置,筹集了1 250 400美元,用于为产品开发和商业化等目标提供资金。 BioNxt Solutions, a bioscience firm, has completed its private placement, raising $1,250,400 to fund product development and commercialization, among other goals. 该公司专注于药物输送技术,如子语言,透皮和口腔平台,针对自身免疫疾病和神经系统疾病等领域. The company focuses on drug delivery technologies like sublingual, transdermal, and oral platforms targeting areas such as autoimmune diseases and neurological disorders. 股份在加拿大、美国和德国进行交易。 Shares are traded in Canada, the U.S., and Germany.